BENGALURU: Telemedicine continues to play a disruptive role in changing the way remote patient monitoring services are provided. Today it’s fast becoming a field where start-ups are shaping the trend with new age technology innovations with the likes of mobile health apps, Internet of Things (IoT), wearable’s, analytics, Big Data, cloud services, artificial intelligence and decision support systems etc.
Launchpad is a platform for enterprising start-ups to showcase their business models, strategies, and innovations. It is being organized as part of the 12th International Conference TELEMEDICON 2016, scheduled to be held between November 10 and 12, 2016, in Bengaluru. Launchpad is expected to give the startups a good exposure to CXOs, technocrats, policy makers and the medical fraternity at large.
The event is being supported by VC’s such as Unitus Seed Fund, a seed-stage venture investment fund based in Bengaluru and Seattle that invests in startups innovating for the masses in India, Axilor Ventures, a new generation platform for supporting early stage entrepreneurs founded by S D Shibulal, Kris Gopalakrishnan, Srinath Batni, Professor Tarun Khanna and Ganapathy Venugopal and Founder Institute, world’s premier startup launch program, providing aspiring and early-stage entrepreneurs with the challenging process, mentor support, and global network needed to launch an enduring company.
According to Naveen Lakkur, Startup Mentor and an Angel Investor, “Launchpad is a great opportunity for startups to gain global exposure and is the best place to showcase business plans and services. It is an ideal platform for entrepreneurs who have business ideas in digital health, businesses looking for growth and expansion, and businesses that are market ready. We look forward to some interesting and innovative plans to be shared during the session.”
Analyzing trends on the business side, Dr Siddhi Ghatwal from Teleradiology Solutions expressed, “The last 50 months have seen 345 deals across segments with Service delivery and Pharmaceuticals accounting for over 60%. This period has also seen more than $6.78 billion of investment across segment with Service delivery and Pharmaceuticals accounting for over 70%.”
“These 345 deals split as 87 pre-seed and seed investments (less than $1.3 million), 137 investments at Series-A and B stages (between $1.3 million and $12 million) and 111 at Series-C and beyond (greater than $12 million). Across tech-led services and IP led products the most active investors are Eight road, IFC, NEA, Norwest, Sequoia, Accel, Qualcomm, Samara and TPG growth,” Dr Ghatwal further added.